Zobrazeno 1 - 10
of 266
pro vyhledávání: '"Ravi Shridhar"'
Autor:
Jiahui Wang, Hao Zhang, Michael Chuong, Kujtim Latifi, Shan Tan, Wookjin Choi, Sarah Hoffe, Ravi Shridhar, Wei Lu
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
We extracted image features from serial 18F-labeled fluorodeoxyglucose (FDG) positron emission tomography (PET) / computed tomography (CT) scans of anal cancer patients for the prediction of tumor recurrence after chemoradiation therapy (CRT). Sevent
Externí odkaz:
https://doaj.org/article/3649eec1856f4c45a9704a054cdb35f0
Autor:
Nikhil G. Rao MD, Ambuj Kumar MD, MPH, Jenny S. Wong MS, Ravi Shridhar MD, PhD, Dharendra Y. Goswami PhD
Publikováno v:
Allergy & Rhinology, Vol 9 (2018)
Background Photoelectrochemical oxidation (PECO) is a new air purification technology developed to reduce circulating indoor allergens. PECO removes particles as small as 0.1 nm with the destruction of organic matter otherwise not trapped by a tradit
Externí odkaz:
https://doaj.org/article/d22c32849b0044039b78275541f45b65
Autor:
Jasmine A. Oliver, Puja Venkat, Jessica M. Frakes, Jason Klapman, Cynthia Harris, Jaime Montilla-Soler, Gautamy C. Dhadham, Baderaldeen A. Altazi, Geoffrey G. Zhang, Eduardo G. Moros, Ravi Shridhar, Sarah E. Hoffe, Kujtim Latifi
Publikováno v:
Endoscopy International Open, Vol 05, Iss 06, Pp E496-E504 (2017)
Background and aims The role of three-dimensional positron emission tomography/computed tomography (3 D PET/CT) in esophageal tumors that move with respiration and have potential for significant mucosal inflammation is unclear. The aim of this study
Externí odkaz:
https://doaj.org/article/d014f573c3064e8cb68772935605c00a
Publikováno v:
Cancer. 129:890-900
Adjuvant capecitabine is considered a standard of care for resected cholangiocarcinoma per the BILCAP trial. The role of adjuvant radiation therapy in that trial was not addressed. This study was designed to examine the outcomes of adjuvant radiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af389956120e2481cb31e4d9557a7fb
https://doi.org/10.1002/cncr.34625
https://doi.org/10.1002/cncr.34625
Autor:
Russell F. Palm, Emanuel Boyer, Dae W. Kim, Jason Denbo, Pamela J. Hodul, Mokenge Malafa, Jason B. Fleming, Ravi Shridhar, Michael D. Chuong, Eric A. Mellon, Jessica M. Frakes, Sarah E. Hoffe
Publikováno v:
HPB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b92da66faddf5003c99d6008022aa3fe
https://doi.org/10.1016/j.hpb.2023.04.019
https://doi.org/10.1016/j.hpb.2023.04.019
Autor:
Bela Kis, Ravi Shridhar, Rahul Mhaskar, Marcell Gyano, Jessica M. Frakes, Ghassan El-Haddad, Junsung Choi, Richard D. Kim, Sarah E. Hoffe
Publikováno v:
Journal of Vascular and Interventional Radiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05dd0a24f2785be6265dd7341da48024
https://doi.org/10.1016/j.jvir.2023.05.026
https://doi.org/10.1016/j.jvir.2023.05.026
Publikováno v:
J Gastrointest Oncol
Background We sought to examine the impact of neoadjuvant chemotherapy (NCT), single agent (SA) or multi-agent (MA) chemotherapy, and chemoradiation (NCRT) on response and survival in pancreatic cancer. Methods Utilizing the National Cancer Database,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82a3211cd49abf36cf7c12e8ba82b0c
https://doi.org/10.21037/jgo.2019.12.03
https://doi.org/10.21037/jgo.2019.12.03
Publikováno v:
Journal of Clinical Oncology. 41:328-328
328 Background: Approximately, 20,640 new esophageal cancers (EC) will be diagnosed in 2022 and this will result in 16,410 deaths. Surgical resection remains the only potentially curative option, however significant morbidity and mortality ensues. Ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::773560ed5ceb85046523516819438f94
https://doi.org/10.1200/jco.2023.41.4_suppl.328
https://doi.org/10.1200/jco.2023.41.4_suppl.328
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 22(3)
Adjuvant chemotherapy or chemoradiation is often recommended for resected pancreatic adenocarcinoma. We sought to examine the impact of these therapies on R1 resected pancreatic cancer.Utilizing the National Cancer Database we identified patients who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124d4c9ac8791d9ad9d93d1199e58d83
https://pubmed.ncbi.nlm.nih.gov/35304103
https://pubmed.ncbi.nlm.nih.gov/35304103
Publikováno v:
Journal of Gastrointestinal Oncology. 10:663-673
BACKGROUND: We sought to examine the impact of neoadjuvant chemotherapy (NCT), single agent or multiagent chemotherapy, and neoadjuvant chemoradiation (NCRT) on survival in pancreatic cancer. METHODS: Utilizing the National Cancer Database, we identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9072e84d0366613534e3557d4b53eef5
https://doi.org/10.21037/jgo.2019.02.09
https://doi.org/10.21037/jgo.2019.02.09